Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Oligosaccharyltransferase complex non-catalytic subunit (OSTC) is a membrane protein that functions as a subunit of the STT3A-containing oligosaccharyltransferase (OST-A) complex in the endoplasmic reticulum. It acts as an adapter that anchors the OST-A complex to the protein-conducting channel (Sec61 complex), facilitating the co-translational transfer of glycans to asparagine residues in nascent polypeptides—an essential step in protein N-glycosylation. OSTC does not possess catalytic activity itself but is critical for proper assembly and localization of the OST-A complex, and its dysfunction can contribute to specific congenital disorders of glycosylation and potentially influence tumor cell biology through altered glycosylation patterns[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Oligosaccharyltransferase complex non-catalytic subunit (OSTC).